89bio Inc Stock Investor Sentiment

ETNB Stock  USD 8.47  0.29  3.55%   
About 68 percent of all 89bio's investors are curious in acquiring. The analysis of the overall investor sentiment regarding 89bio Inc suggests that quite a large number of traders are confidant. The current market sentiment, together with 89bio's historical and current headlines, can help investors time the market. In addition, many technical investors use 89bio Inc stock news signals to limit their universe of possible portfolio assets.

Comfort Level 68

 Interested

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use 89bio's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward 89bio Inc.

89bio Historical Sentiment

Although 89bio's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding 89bio, such as negative comments on social media and news outlets, may cause fear in the market and push 89bio's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of 89bio.
  

89bio Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards 89bio can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
2 days ago at zacks.com         
Disposition of 1050 shares by Le-nguyen Quoc of 89bio at 10.57 subject to Rule 16b-3
zacks News
few days ago at finance.yahoo.com         
Bears are Losing Control Over 89BIO , Heres Why Its a Buy Now
Yahoo News
few days ago at zacks.com         
Bears are Losing Control Over 89BIO , Heres Why Its a Buy Now
zacks News
over a week ago at news.google.com         
Rhumbline Advisers Has 1.02 Million Stock Position in 89bio, Inc. - Defense World
Google News at Macroaxis
over a week ago at finance.yahoo.com         
Is 89BIO Stock Outpacing Its Medical Peers This Year?
Yahoo News
over a week ago at zacks.com         
FDA Accepts RHHBYs sNDA for Gazyva in Treating Lupus Nephritis
zacks News
over a week ago at gurufocus.com         
89bio to Participate in the Leerink Partners Global Healthcare Conference
Gurufocus Stories at Macroaxis
over a week ago at gurufocus.com         
89bio Inc to Participate in Leerink Partners Global Healthcare Conference
Gurufocus Stories at Macroaxis
over a week ago at thelincolnianonline.com         
HC Wainwright Reaffirms Buy Rating for 89bio
news
over two weeks ago at gurufocus.com         
Decoding 89bio Inc A Strategic SWOT Insight
Gurufocus Stories at Macroaxis
over two weeks ago at zacks.com         
Perrigos Q4 Earnings Beat Estimates, Revenues Decline YY
zacks News
over two weeks ago at zacks.com         
IOVA Q4 Earnings Beat, Stock Down on Looming Economic Uncertainty
zacks News
over two weeks ago at gurufocus.com         
89bio Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates
Gurufocus Stories at Macroaxis
over two weeks ago at gurufocus.com         
Acquisition by Mansbach Harry H of 48750 shares of 89bio subject to Rule 16b-3
Gurufocus Stories at Macroaxis
over two weeks ago at gurufocus.com         
89bio Inc Reports Significant Progress in Clinical Trials and Financial Performance
Gurufocus Stories at Macroaxis
Far too much social signal, news, headlines, and media speculation about 89bio that are available to investors today. That information is available publicly through 89bio media outlets and privately through word of mouth or via 89bio internal channels. However, regardless of the origin, that massive amount of 89bio data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of 89bio news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of 89bio relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to 89bio's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive 89bio alpha.

89bio Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Jane Street Group LLC Has 1.03 Million Stock Holdings in 89bio, Inc. - MarketBeat
12/31/2024
2
Disposition of 3821 shares by Mansbach Harry H of 89bio at 16.61 subject to Rule 16b-3
01/08/2025
3
Disposition of 10963 shares by Le-nguyen Quoc of 89bio at 6.49 subject to Rule 16b-3
01/15/2025
4
Acquisition by Mcwherter Charles of 5000 shares of 89bio at 6.55 subject to Rule 16b-3
01/21/2025
5
Acquisition by Mcwherter Charles of 10000 shares of 89bio at 6.71 subject to Rule 16b-3
01/22/2025
6
Traders Buy High Volume of Call Options on 89bio
01/27/2025
7
Disposition of 1014 shares by Mansbach Harry H of 89bio at 15.46 subject to Rule 16b-3
01/28/2025
8
Acquisition by Ra Capital Management, L.p. of 5714285 shares of 89bio at 8.75 subject to Rule 16b-3
01/30/2025
9
Acquisition by Francis Sarena of 53750 shares of 89bio subject to Rule 16b-3
01/31/2025
10
89bio Announces Closing of its Public Offering and Full Exercise of Underwriters Option to ...
02/03/2025
11
89bio Shares Up 7.1 percent Heres What Happened
02/07/2025
12
89bio, Inc. Shares Sold by abrdn plc - MarketBeat
02/13/2025
13
Disposition of 1050 shares by Mansbach Harry H of 89bio at 10.57 subject to Rule 16b-3
02/14/2025
14
Acquisition by Babler Martin of 56400 shares of 89bio at 9.6 subject to Rule 16b-3
02/18/2025
15
Should You Buy 89BIO After Golden Cross
02/20/2025
16
89bio GAAP EPS of -1.02
02/27/2025
17
Decoding 89bio Inc A Strategic SWOT Insight
02/28/2025
18
89bio to Participate in the Leerink Partners Global Healthcare Conference
03/03/2025
19
Rhumbline Advisers Has 1.02 Million Stock Position in 89bio, Inc. - Defense World
03/07/2025
20
Disposition of 1050 shares by Le-nguyen Quoc of 89bio at 10.57 subject to Rule 16b-3
03/14/2025

Complementary Tools for 89bio Stock analysis

When running 89bio's price analysis, check to measure 89bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 89bio is operating at the current time. Most of 89bio's value examination focuses on studying past and present price action to predict the probability of 89bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 89bio's price. Additionally, you may evaluate how the addition of 89bio to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas